2021年最新SCI期刊影响因子查询系统
PULMONARY PHARMACOLOGY & THERAPEUTICS 期刊详细信息
基本信息
期刊名称 | PULMONARY PHARMACOLOGY & THERAPEUTICS PULMONARY PHARMACOLOGY & THERAPEUTICS |
---|---|
期刊ISSN | 1094-5539 |
期刊官方网站 | http://www.journals.elsevier.com/pulmonary-pharmacology-and-therapeutics/#description |
是否OA | 否 |
出版商 | Academic Press Inc. |
出版周期 | Bimonthly |
始发年份 | 1997 |
年文章数 | 96 |
最新影响因子 | 3.282(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | PHARMACOLOGY & PHARMACY 药学3区 | 否 | 否 |
RESPIRATORY SYSTEM 呼吸系统4区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 2.74 | 0.952 | 0.809 |
Medicine Biochemistry, medical |
14 / 51 | 73% |
|||
Medicine Pulmonary and Respiratory Medicine |
32 / 134 | 76% |
|||
Medicine Pharmacology (medical) |
66 / 232 | 71% |
补充信息
自引率 | 7.10% |
---|---|
H-index | 61 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1094-5539%5BISSN%5D |
投稿指南
期刊投稿网址 | https://www.evise.com/evise/faces/pages/navigation/NavController.jspx? |
---|---|
收稿范围 | Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews. Research Areas Include: • All major diseases of the lung • Physiology • Pathology • Drug delivery • Metabolism • Pulmonary Toxicology Before submitting, please note the "Rules of 5" defining immediate rejection criteria of PPT: 1. Out of scope: The paper should report on the use of pharmacological or toxicological studies (positive or negative) that are directly related to Pulmonary Pharmacology & Therapeutics. Immediate rejection criteria are: a) Testing of extracts or plant parts that are not characterized b) Case Reports or n=1 studies 2. Too preliminary: A paper must be based on a thorough and extensive study, using proper controls Immediate rejection criteria are: a) In vitro studies with a single dose, or very high concentration b) Single dose studies with very few animals, no dose-response studies c) No proper controls. d) Repetition or confirmation of an earlier work 3. Unethical: The study must have been carried under appropriate ethical approval for the study (either animal or human). 4. Inappropriate experiments or lacking essential detail Immediate rejection criteria are: a) Wrong species or lacking details on the exact number of animals/subjects used b) No details of structure if a new drug is used for the first time 5. Lack of novelty: The study must represent a novel approach to the field. Immediate rejection criteria are: a) Repetition of well known data b) No advance of knowledge in the field Note that only manuscripts written in good English will be considered by the Editors(British usage is preferred). |
收录体裁 | original research papers review articles book reviews. |
投稿指南 | https://www.elsevier.com/journals/pulmonary-pharmacology-and-therapeutics/1094-5539/guide-for-authors |
投稿模板 | |
参考文献格式 | https://www.elsevier.com/journals/pulmonary-pharmacology-and-therapeutics/1094-5539/guide-for-authors |
编辑信息 |